Shipeng Cheng

Key Laboratory Of Multicellular Systems, 320 Yueyang Road
Yueyang, 200031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

CD74-Targeting Antibody-Drug Conjugate Enhances Immunosuppression of Glucocorticoid in Systemic Lupus Erythematosus.

CD74-Targeting Antibody-Drug Conjugate Enhances Immunosuppression of Glucocorticoid in Systemic Lupus Erythematosus.

Journal: International journal of molecular sciences

Published: August 18, 2025

Acute stress alleviates type 2 lung inflammation by restricting ILC2s through corticosterone-glucocorticoid receptor signaling.

Acute stress alleviates type 2 lung inflammation by restricting ILC2s through corticosterone-glucocorticoid receptor signaling.

Journal: Cellular & molecular immunology

Published: July 17, 2025

TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function.

TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function.

Journal: Oncoimmunology

Published: April 28, 2025

An anti-CD47 antibody binds to a distinct epitope in a novel metal ion-dependent manner to minimize cross-linking of red blood cells.

An anti-CD47 antibody binds to a distinct epitope in a novel metal ion-dependent manner to minimize cross-linking of red blood cells.

Journal: The Journal of biological chemistry

Published: December 29, 2024

Bispecific targeting of 4-1BB and CCR8 boosts antitumor immunity via Ti-Treg depletion and CD8+ activation.

Bispecific targeting of 4-1BB and CCR8 boosts antitumor immunity via Ti-Treg depletion and CD8+ activation.

Journal: iScience

Published: December 04, 2024

Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B.

Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B.

Journal: Science China. Life sciences

Published: May 18, 2024

Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responses.

Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responses.

Journal: Oncoimmunology

Published: August 14, 2023

The TRIM37 variants in Mulibrey nanism patients paralyze follicular helper T cell differentiation.

The TRIM37 variants in Mulibrey nanism patients paralyze follicular helper T cell differentiation.

Journal: Cell discovery

Published: January 18, 2023

Solar ultraviolet B radiation promotes α-MSH secretion to attenuate the function of ILC2s via the pituitary-lung axis.

Solar ultraviolet B radiation promotes α-MSH secretion to attenuate the function of ILC2s via the pituitary-lung axis.

Journal: Nature communications

Published: January 04, 2023

Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation.

Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation.

Journal: Cellular & molecular immunology

Published: December 09, 2022

HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.

HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.

Journal: Cellular & molecular immunology

Published: August 18, 2022

Cancer metabolism and tumor microenvironment: fostering each other?

Cancer metabolism and tumor microenvironment: fostering each other?

Journal: Science China. Life sciences

Published: May 08, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026